[go: up one dir, main page]

AU2001287907A1 - Diuretic or sulphonylurea for use in antiviral treatment - Google Patents

Diuretic or sulphonylurea for use in antiviral treatment

Info

Publication number
AU2001287907A1
AU2001287907A1 AU2001287907A AU8790701A AU2001287907A1 AU 2001287907 A1 AU2001287907 A1 AU 2001287907A1 AU 2001287907 A AU2001287907 A AU 2001287907A AU 8790701 A AU8790701 A AU 8790701A AU 2001287907 A1 AU2001287907 A1 AU 2001287907A1
Authority
AU
Australia
Prior art keywords
diuretic
sulphonylurea
antiviral treatment
treatment
antiviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001287907A
Inventor
Christopher Edward Hartley
Ian Stuart Pardoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henderson Morley Research and Development Ltd
Original Assignee
Henderson Morley Research and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0023199A external-priority patent/GB2367242B/en
Priority claimed from GB0104031A external-priority patent/GB0104031D0/en
Priority claimed from GB0104030A external-priority patent/GB0104030D0/en
Priority claimed from GB0114947A external-priority patent/GB2376628B/en
Application filed by Henderson Morley Research and Development Ltd filed Critical Henderson Morley Research and Development Ltd
Publication of AU2001287907A1 publication Critical patent/AU2001287907A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A diuretic, e.g., loop diuretic or thiazide, or a sulphylurea is useful in the treatment of DNA viral infections.
AU2001287907A 2000-09-21 2001-09-21 Diuretic or sulphonylurea for use in antiviral treatment Abandoned AU2001287907A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB0023199 2000-09-21
GB0023199A GB2367242B (en) 2000-09-21 2000-09-21 Antiviral treatment
GB0104031A GB0104031D0 (en) 2001-02-19 2001-02-19 Antiviral treatment
GB0104031 2001-02-19
GB0104030A GB0104030D0 (en) 2001-02-19 2001-02-19 Antiviral treatment
GB0104030 2001-02-19
GB0114947 2001-06-19
GB0114947A GB2376628B (en) 2001-06-19 2001-06-19 Treatment of DNA viral infections in cats
PCT/GB2001/004206 WO2002024207A1 (en) 2000-09-21 2001-09-21 Diuretic or sulphonylurea for use in antiviral treatment

Publications (1)

Publication Number Publication Date
AU2001287907A1 true AU2001287907A1 (en) 2002-04-02

Family

ID=27447886

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001287907A Abandoned AU2001287907A1 (en) 2000-09-21 2001-09-21 Diuretic or sulphonylurea for use in antiviral treatment

Country Status (6)

Country Link
US (1) US20040034016A1 (en)
EP (1) EP1322316B1 (en)
AT (1) ATE435019T1 (en)
AU (1) AU2001287907A1 (en)
DE (1) DE60139134D1 (en)
WO (1) WO2002024207A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1873101A (en) * 1999-12-30 2001-07-16 Henderson Morley Research And Development Limited Synergistic treatment of dna viral infections
EP3257509A1 (en) 2003-02-12 2017-12-20 Georgetown University Use of artemisinin and related compounds for treating anorectal squamous cell cancer induced by human papilloma virus
WO2005023182A2 (en) 2003-08-28 2005-03-17 Nitromed, Inc. Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
JP2008531579A (en) 2005-02-24 2008-08-14 ニトロメッド インコーポレーティッド Nitric oxide enhanced diuretic compounds, compositions and methods of use
GB0517840D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Topical anti viral formulations
GB0517838D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Transdermal active principle delivery means
WO2014164730A2 (en) 2013-03-12 2014-10-09 The Board Of Trustees Of The Leland Stanford Junior University Modulation of cellular dna repair activity to intercept malignancy
US10624923B2 (en) 2014-03-26 2020-04-21 Enrique G. Gutierrez Compositions and related methods for treating and preventing viral and retroviral infections
US11260074B2 (en) 2014-03-26 2022-03-01 Enrique G. Gutierrez Compositions and related methods for reconstituting the immune system of a subject

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5855411A (en) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd Base material composition and medicinal composition for external use
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
JPH07179347A (en) * 1993-12-21 1995-07-18 Showa Shell Sekiyu Kk Antiviral composition
US5686100A (en) * 1994-11-22 1997-11-11 E.R. Squibb & Sons, Inc. Prophylactic and therapeutic treatment of skin sensitization and irritation
FR2770925B1 (en) * 1997-11-12 2000-01-07 Sagem METHOD FOR TRANSMITTING REMOTE CONTROLS
AU1873101A (en) * 1999-12-30 2001-07-16 Henderson Morley Research And Development Limited Synergistic treatment of dna viral infections
WO2001049242A2 (en) * 1999-12-30 2001-07-12 Henderson Morley Research And Development Limited Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside

Also Published As

Publication number Publication date
ATE435019T1 (en) 2009-07-15
WO2002024207A1 (en) 2002-03-28
DE60139134D1 (en) 2009-08-13
US20040034016A1 (en) 2004-02-19
EP1322316B1 (en) 2009-07-01
EP1322316A1 (en) 2003-07-02

Similar Documents

Publication Publication Date Title
AU2001248331A1 (en) Medicaments against viral diseases
DE122012000038I1 (en) HIV-inhibiting pyrimidine derivatives.
DE69909756D1 (en) ANTIVIRAL PYRIMIDINE DERIVATIVES
FI955315A0 (en) HIV protease inhibitors useful in the treatment of AIDS
SG146442A1 (en) Sulphonamide derivatives, their preparation and use as medicaments
EP1230925B8 (en) Use of a trifluridine derivative alone or combined with a thymidine phosphorylase inhibitor for the treatment of hiv
MY117789A (en) Pyrroloquinolones as antiviral agents
AU2003288869A1 (en) PYRAZOLO (3,4-d) PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION
AU2001287907A1 (en) Diuretic or sulphonylurea for use in antiviral treatment
MXPA03009602A (en) Nociceptin analogs.
TR200401363T4 (en) Treatment of DNA viral infections
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
USD470178S1 (en) Compass
MXPA03001081A (en) Anti-inflammatory medicament.
WO2001025239A3 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2002215979A1 (en) Use of pyrazolo(4,3-D)pyrimidines
WO2001051479A3 (en) Tricyclic compounds with antiviral activity
AU1873101A (en) Synergistic treatment of dna viral infections
USD459484S1 (en) Arbor
CA2445620A1 (en) Tetracyclic compounds as pde5-inhibitors
USD466618S1 (en) Arbor
USD523162S1 (en) Flashlight body
USD459485S1 (en) Arbor
USD458692S1 (en) Arbor
AU7438301A (en) The use of synthetic, non-hormonal 21-aminosteroids, derivatives, metabolites and precursors thereof in the treatment of viral infections